Related Experiment Video
Updated: Sep 28, 2025

Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
Membrane Anchorage-Induced (MAGIC) Knockdown of Non-synonymous Point Mutations
1Max Planck Institute of Biochemistry, Department of Molecular Biology, Am Klopferspitz 18, 82152-, Martinsried, Germany.
This study introduces MAGIC knockdown, a novel method to inhibit specific disease-associated protein variants without altering the human genome. This approach targets non-synonymous single nucleotide variants (nsSNVs), paving the way for personalized medicine and variant functional studies.
Area of Science:
- Genetics and Molecular Biology
- Personalized Medicine
- Drug Discovery
Background:
- Personalized medicine requires targeted inhibition of disease-associated protein variants.
- Non-synonymous single nucleotide variants (nsSNVs) are a major barrier due to interpretation challenges.
- Current methods lack the ability to inhibit nsSNVs without genome editing.
Purpose of the Study:
- To develop a method for allele-specific inhibition of nsSNVs without genome editing.
- To investigate the phenomenon of membrane anchorage-induced (MAGIC) knockdown.
- To enable functional interrogation and therapeutic suppression of nsSNVs.
Main Methods:
- Utilized membrane anchorage-induced (MAGIC) knockdown by tethering point mutation-specific monoclonal antibodies (mAb) to the inner membrane.
- Demonstrated allele-specific inhibition of protein and mRNA expression.
- Employed a membrane-anchored single domain intrabody to confirm the mechanism distinct from protein degradation.
Main Results:
- Successfully inhibited expression of disease-associated nsSNVs, including FGFR4 p.G388R, KRAS p.G12D, and BRAF p.V600E.
- Showcased MAGIC knockdown as an effective strategy for allele-specific protein inhibition.
- Validated the mechanism of MAGIC knockdown, independent of protein degradation pathways.
Conclusions:
- MAGIC knockdown offers a novel approach for inhibiting specific amino-acid-altering nsSNVs.
- This method facilitates functional studies of nsSNVs and offers potential for therapeutic applications.
- Opens new avenues for targeting undruggable protein variants in personalized medicine.
Related Concept Videos
Point and Frameshift Mutations
In-vitro Mutagenesis
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Mutations
Experimental RNAi

